Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

Oncomine™ Comprehensive Assay v3M

Laboratory Developed Test
Related tests:
The Oncomine™ Comprehensive Assay v3 contains targeted, multi-biomarker panels that enable simultaneous detection of hundreds of variants across 161 genes relevant to solid tumors. This assay allows concurrent analysis of DNA and RNA to simultaneously detect multiple types of variants, including hotspots, single nucleotide variants (SNVs), insertions and deletions (INDELs), copy number variants (CNVs), and gene fusions, in a single workflow.
Solid Tumor
AKT1 (V-akt murine thymoma viral oncogene homolog 1), AKT2 (V-akt murine thymoma viral oncogene homolog 2), AKT3 (V-akt murine thymoma viral oncogene homolog 3), ALK (Anaplastic lymphoma kinase), AR (Androgen receptor), ARAF (A-Raf Proto-Oncogene)
See More ...
Next-Generation Sequencing (NGS)